Alaunos Therapeutics (TCRT) Interest Coverage Ratio (2021 - 2023)
Alaunos Therapeutics (TCRT) reported Interest Coverage Ratio of 7.47 for Q2 2023, up 40.1% on a YoY basis from 5.33 in Q2 2022, and up 34.09% quarter-over-quarter from 11.34 in Q1 2023.
Alaunos Therapeutics (TCRT) Interest Coverage Ratio (2021 - 2023) Analysis & Trends
Alaunos Therapeutics has reported Interest Coverage Ratio for 3 years, with the latest figure at 7.47 in Q2 2023.
- For the quarter ending Q2 2023, Interest Coverage Ratio rose 40.1% year-over-year to 7.47; the trailing twelve-month figure through Mar 2024 stood at 24.66 (down 126.7% YoY), and the FY2023 full-year result was 17.84, down 60.27% from the prior year.
- Interest Coverage Ratio for Q2 2023 stood at 7.47, up from 11.34 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 7.47 in Q2 2023, with the low at 55.74 in Q3 2021.
- Historically, Interest Coverage Ratio has averaged 16.85 across 3 years, with a median of 11.91 in 2022.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio soared 81.47% — and 2023, when it climbed 12.63%.
- Alaunos Therapeutics' Interest Coverage Ratio stood at 14.83 in 2021, then soared by 35.31% to 9.6 in 2022, then gained by 22.11% to 7.47 in 2023.
- The last three Interest Coverage Ratio figures came in at 7.47 (Q2 2023), 11.34 (Q1 2023), and 9.6 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -7.47 |
| Mar 31, 2023 | -11.34 |
| Dec 31, 2022 | -9.60 |
| Sep 30, 2022 | -10.33 |
| Jun 30, 2022 | -12.48 |
| Mar 31, 2022 | -12.98 |
| Dec 31, 2021 | -14.83 |
| Sep 30, 2021 | -55.74 |